| Identification | Back Directory | [Name]
Phenol, 4-[(1R)-5-[[(R)-[(2R,4S)-4-(3-chlorophenyl)-2-oxido-1,3,2-dioxaphosphorinan-1-yl][(2R,6S)-2-oxido-1,3,2-dioxaphosphorinan-3-yl]phosphinyl]methoxy]-2,3-dihydro-7-methyl-1H-inden-1-yl]-2-(1-methylethyl)- | [CAS]
2656400-84-7 | [Synonyms]
THR-β agonist 3
Phenol, 4-[(1R)-5-[[(R)-[(2R,4S)-4-(3-chlorophenyl)-2-oxido-1,3,2-dioxaphosphorinan-1-yl][(2R,6S)-2-oxido-1,3,2-dioxaphosphorinan-3-yl]phosphinyl]methoxy]-2,3-dihydro-7-methyl-1H-inden-1-yl]-2-(1-methylethyl)- | [Molecular Formula]
C29H32ClO5P | [MOL File]
2656400-84-7.mol | [Molecular Weight]
526.99 |
| Hazard Information | Back Directory | [Uses]
THR-β agonist 3 is a potent agonist of THR-β. THR-β agonist 3 has the potential for the research of metabolic diseases such as obesity, hyperlipidemia, hypercholesterolemia, diabetes and other conditions such as steatosis and non-alcoholic steatohepatitis (NASH), atherosclerosis and other related conditions and diseases (extracted from patent WO2021129827A1, compound 6)[1]. | [References]
[1] Li Peng, et al. Benzo-fused ring compounds. Patent WO2021129827A1. |
|
| Company Name: |
Biorbyt Ltd.
|
| Tel: |
+44 (0)1223 859 353 |
| Website: |
http://www.biorbyt.com |
|